Exterro Launches Industry’s First Autonomous AI Engine to Eliminate Up to 95% of manual Subpoena Work and Reclaim 7,500 Enterprise Hours 
CleverTap and Rabbit Rewards win Silver at Thailand MarTech Awards 2026 for real-time, agentic customer engagement 
Gold Peak completes a HK$675 million Green and Sustainability Linked Term Loan Facility Longeveron Announces Potential Biomarker Correlating with Lomecel-B Bioactivity
Lomecel-B significantly decreased biomarker Tie-2 in Aging Frailty subjects at 270 days compared to placebo…
Rentschler Biopharma Inc. Recognized by Massachusetts House of Representatives as Manufacturer of the Year for District
Company honored at 6th Annual Massachusetts Legislative Manufacturing Caucus Awards ceremony LAUPHEIM, Germany and MILFORD,…
All Endpoints Met in Hepion Pharmaceuticals’ Drug-Drug Interaction Study with CRV431
EDISON, N.J., Sept. 29, 2021 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage…
Denali Therapeutics Announces Upcoming Presentations on EIF2B Activator DNL343 and RIPK1 Inhibitor SAR443820/DNL788 at the 2021 Annual Northeast Amyotrophic Lateral Sclerosis (NEALS) Meeting
Denali to present results from Phase 1 healthy volunteer study of EIF2B activator DNL343 Sanofi…
Editas Medicine Announces Positive Initial Clinical Data from Ongoing Phase 1/2 BRILLIANCE Clinical Trial of EDIT-101 for LCA10
No serious adverse events or dose-limiting toxicities observed to date Efficacy signals in the mid-dose…
TNFα-supplemented DL-4 culture system supports first-in-clinic Smart Immune ProTcell™ technology for immuno-deficient patients fighting cancers and infections
Rapid reset of immune system can provide marked benefits in clinical settings where patients are…
Mountain Valley MD Holdings Announces Letter of Intent with Red White and Bloom Brands Inc.
TORONTO, Sept. 29, 2021 (GLOBE NEWSWIRE) — Mountain Valley MD Holdings Inc. (the “Company” or…
Enlivex to Present at Reuters Events’ Cell & Gene Therapy USA 2021
Nes-Ziona, Israel, Sept. 29, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”),…
Theratechnologies to Announce Financial Results for Its Third Quarter Fiscal 2021
MONTREAL, Sept. 29, 2021 (GLOBE NEWSWIRE) — Theratechnologies Inc. (TSX: TH) (NASDAQ: THTX) (Theratechnologies), a…
SCYNEXIS Presents Interim Analysis from FURI at Virtual IDWeek 2021 Showing Favorable Therapeutic Response in Severe Hospital-Based Fungal Infections Treated with Oral Ibrexafungerp
Subpopulation analysis of 74 patients from ongoing Phase 3 FURI study demonstrated similar efficacy against…
Scopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Release of Preclinical Data Being Presented at 17th Annual Meeting of the Oligonucleotide Therapeutics Society
Data from two different studies benchmark Duet’s proprietary bifunctional oligonucleotides against immune checkpoint inhibitors (“Checkpoint…
Medolife Rx Files Bi-Annual Report With Ministry of Environment in the Dominican Republic, Details Reservation Expansion and Exceeds Regulatory Expectations
BURBANK, Calif., Sept. 29, 2021 (GLOBE NEWSWIRE) — via NewMediaWire – Medolife Rx, Inc. (“Medolife”),…
Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a Clinical Trial of WVE-N531 in Duchenne Muscular Dystrophy
Trial is expected to enroll 15 boys with DMD amenable to exon 53 skipping First…
Athira Pharma to Present Updates from Phase 2/3 Trials of ATH-1017 at the 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
BOTHELL, Wash., Sept. 29, 2021 (GLOBE NEWSWIRE) — Athira Pharma, Inc. (NASDAQ: ATHA), a late…
Immutep Receives A$3.4 million R&D Tax Incentive from French Government
SYDNEY, AUSTRALIA, Sept. 29, 2021 (GLOBE NEWSWIRE) — Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep“…
Krystal Biotech Receives Approval from the Human Research Ethics Committee in Australia for Phase 1 Trial of KB407 for Cystic Fibrosis
– KB407 is an investigational inhaled gene therapy derived from Krystal’s clinically validated redosable gene…
Neoleukin Therapeutics Announces Oral Presentation at IDWeek 2021 of Data Demonstrating that NL-CVX1, a Computationally Designed De Novo Protein, Can Block Infection by SARS-CoV-2 Viral Variants of Concern
– Single intranasal dose of NL-CVX1 in mice prevents infection by multiple variants of SARS-CoV-2…
Kolab Project Launches 132 Series Live Resin Soft Chews, Canada’s First Live Resin Cannabis Edible
Kolab Project 132 Series Live Resin Soft Chews Kolab Project 132 Series Live Resin Soft…
Allena Pharmaceuticals Commences Dosing of Gout Patients in Second Phase 2a Trial of ALLN-346
– Fourteen-day study focused on high unmet need in patients with gout and chronic kidney…
Cidara Therapeutics to Present New Data for Rezafungin at TIMM Congress
SAN DIEGO, Sept. 29, 2021 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…